Livongo Health
Livongo Health raises $105M Series E at $1.1B valuation
Quick Facts
Livongo Health: Series E Funding Round
Livongo Health has successfully raised $105M in Series E funding, reaching a valuation of $1.1B.
Company Overview
Chronic condition management platform
Funding Details
The Series E round was led by General Catalyst, with participation from Kleiner Perkins, Venrock, Kinnevik AB.
Company Information
- Headquarters: 150 West Evelyn Avenue, Mountain View, CA 94041
- Founded: 2014
- Employees: 1000+
- Category: HealthTech
Investment
Livongo Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- General Catalyst: Verified investor in Series E
- Kleiner Perkins: Verified investor in Series E
- Venrock: Verified investor in Series E
- Kinnevik AB: Verified investor in Series E
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
